1. Home
  2. INM vs AKAN Comparison

INM vs AKAN Comparison

Compare INM & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • AKAN
  • Stock Information
  • Founded
  • INM 1981
  • AKAN 2021
  • Country
  • INM Canada
  • AKAN United Kingdom
  • Employees
  • INM N/A
  • AKAN N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • AKAN Medicinal Chemicals and Botanical Products
  • Sector
  • INM Health Care
  • AKAN Health Care
  • Exchange
  • INM Nasdaq
  • AKAN Nasdaq
  • Market Cap
  • INM 2.3M
  • AKAN 2.4M
  • IPO Year
  • INM N/A
  • AKAN 2022
  • Fundamental
  • Price
  • INM $3.12
  • AKAN $1.75
  • Analyst Decision
  • INM
  • AKAN
  • Analyst Count
  • INM 0
  • AKAN 0
  • Target Price
  • INM N/A
  • AKAN N/A
  • AVG Volume (30 Days)
  • INM 84.1K
  • AKAN 120.7K
  • Earning Date
  • INM 02-12-2025
  • AKAN 02-28-2025
  • Dividend Yield
  • INM N/A
  • AKAN N/A
  • EPS Growth
  • INM N/A
  • AKAN N/A
  • EPS
  • INM N/A
  • AKAN N/A
  • Revenue
  • INM $4,832,013.00
  • AKAN $2,508,317.00
  • Revenue This Year
  • INM N/A
  • AKAN N/A
  • Revenue Next Year
  • INM N/A
  • AKAN N/A
  • P/E Ratio
  • INM N/A
  • AKAN N/A
  • Revenue Growth
  • INM N/A
  • AKAN N/A
  • 52 Week Low
  • INM $2.42
  • AKAN $1.22
  • 52 Week High
  • INM $15.70
  • AKAN $47.52
  • Technical
  • Relative Strength Index (RSI)
  • INM 37.82
  • AKAN 56.48
  • Support Level
  • INM $3.03
  • AKAN $1.46
  • Resistance Level
  • INM $3.48
  • AKAN $1.78
  • Average True Range (ATR)
  • INM 0.20
  • AKAN 0.10
  • MACD
  • INM 0.05
  • AKAN 0.00
  • Stochastic Oscillator
  • INM 35.59
  • AKAN 65.91

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About AKAN Akanda Corp.

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.

Share on Social Networks: